AVASCULAR NECROSIS
Clinical trials for AVASCULAR NECROSIS explained in plain language.
Never miss a new study
Get alerted when new AVASCULAR NECROSIS trials appear
Sign up with your email to follow new studies for AVASCULAR NECROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
10-Year shoulder implant study launches to track pain relief and mobility
Disease control Recruiting nowThis study tracks 300 adults getting a shoulder replacement with the Perform Humeral System to manage conditions like arthritis, bone death, or rotator cuff tears. Researchers will measure pain, function, and safety for up to 10 years after surgery. The goal is to confirm the dev…
Matched conditions: AVASCULAR NECROSIS
Sponsor: Stryker Trauma and Extremities • Aim: Disease control
Last updated May 17, 2026 02:17 UTC
-
New knee implant study aims to improve mobility for arthritis sufferers
Disease control Recruiting nowThis study is testing a new knee implant (Persona) in 760 people who need knee replacement surgery due to arthritis or other knee problems. The goal is to see if the implant is safe, works well, and helps patients move better and feel less pain. Participants will be followed for …
Matched conditions: AVASCULAR NECROSIS
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New shoulder implant under watch: will it hold up?
Disease control Recruiting nowThis study is checking how well the Medacta Shoulder System works in 200 people who need shoulder replacement due to arthritis, rotator cuff tears, fractures, or other conditions. Researchers will track how long the implant lasts and how much shoulder function improves over time.…
Matched conditions: AVASCULAR NECROSIS
Sponsor: Medacta International SA • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Weekly pill trial aims to ease agonizing bone pain for sickle cell patients
Disease control Recruiting nowThis study is testing if a weekly pill called alendronate is safe and can help adults with sickle cell disease who have a painful bone condition called osteonecrosis. Researchers will give the pill to about 30 participants for 6 months to see if it reduces pain and improves bone …
Matched conditions: AVASCULAR NECROSIS
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Apr 13, 2026 20:21 UTC